HSPA2 has been identified as a potential cancer-promoting protein expressed at abnormal levels in a subset of human cancers, such as breast cancer[7], cervical cancer[8], bladder urothelial cancer[9], nasopharyngeal carcinoma[10] and malignant tumors[11]. Here, HSPA2 is linked to bladder transitional cell carcinoma.